Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Novo Nordisk Awaiting FDA Comment On Diabetes Drug

Posted Dec 30 2009 12:00am

So are we -- it is very much overdue. European regulators cleared VICTOZA (liraglutide), a once-daily BYETTA competitor, at the end of June 2009.

Read the full article here.

Labels: , , ,

Post a comment
Write a comment: